Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-22-063972
Filing Date
2022-05-23
Accepted
2022-05-23 18:49:42
Documents
1
Period of Report
2022-05-19

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2216669-3_4seq1.html 4  
1 OWNERSHIP DOCUMENT tm2216669-3_4seq1.xml 4 4177
  Complete submission text file 0001104659-22-063972.txt   5398
Mailing Address
Business Address
MUELLER PETER (Reporting) CIK: 0001256126 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38410 | Film No.: 22953351

Mailing Address 555 LONG WHARF DRIVE NEW HAVEN CT 06511
Business Address 555 LONG WHARF DRIVE NEW HAVEN CT 06511 203-643-8060
BioXcel Therapeutics, Inc. (Issuer) CIK: 0001720893 (see all company filings)

EIN.: 821386754 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations